Volume 3, Issue 12, Pages 1-2 (December 2008)
4 of 31
PREVIEW
FULL TEXT
FULL-TEXT PDF (267 KB)
CITATION ALERT
CITED BY
RELATED ARTICLES
EXPORT CITATION
EMAIL TO A COLLEAGUE
RIGHTS/PERMISSIONS
NEED REPRINTS?
BOOKMARK ARTICLE
CHICAGO — Hypothyroidism is a frequent complication of many of the oral tyrosine kinase inhibitors being developed to treat malignancies, according to endocrinologist Jerome M. Hersh-man.
PII: S1558-0164(08)70426-7
doi:10.1016/S1558-0164(08)70426-7
© 2008 Elsevier Inc. All rights reserved.
Copyright © 2012 Elsevier Inc. All rights reserved. | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.